Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
Clinical trial NCT03553550 · TERMINATED
Trial details
- NCT number
- NCT03553550
- Sponsor
- Addario Lung Cancer Medical Institute
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-11-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.